KathleenColleranMD(She/Her)

PubMed

• 18 citations
  Improvement in insulin sensitivity during mifepristone treatment of Cushing syndrome: early and late effects.
  Amisha Wallia, Kathleen Colleran, Jonathan Q. Purnell, Coleman Gross, Mark E. Molitch> ;Diabetes Care. 2013 Sep 1
• Long-term effects of the Diabetes Prevention Program interventions on cardiovascular risk factors: a report from the DPP Outcomes Study.
  Diabetes Prevention Program Outcomes Study Research Group, Orchard TJ, Temprosa M, Barrett-Connor E, Fowler SE, Goldberg RB, Mather KJ, Marcovina SM, Montez M, Ratner ...> ;Diabetic medicine : a journal of the British Diabetic Association.
• 296 citations
  Expanding access to hepatitis C virus treatment--Extension for Community Healthcare Outcomes (ECHO) project: disruptive innovation in specialty care.
  Sanjeev Arora, Summers Kalishman, Karla Thornton, Denise Dion, Glen H. Murata, Paulina Deming, Brooke Parish, John B. Brown, Miriam Komaromy, Kathleen Colleran, Arthur...> ;Hepatology. 2010 Sep 1
• 28 citations
  Patient knowledge improves glycemic control: is it time to go back to the classroom?
  Srinivas Panja, Brian Starr, Kathleen Colleran> ;Journal of Investigative Medicine. 2005 Jul 1
• 3 citations
  Methimazole-induced hypothyroidism paradoxically decreases homocysteine.
  Kathleen Colleran, Leonard A. Romero, Dalice A. Upton, Mark R. Burge> ;Metabolism. 2005 Apr 1
• 22 citations
  Potential association of thyrotoxicosis with vitamin B and folate deficiencies, resulting in risk for hyperhomocysteinemia and subsequent thromboembolic events.
  Kathleen Colleran, Devona M. Ratliff, Mark R. Burge> ;Endocrine Practice. 2003 Jul 1
• 30 citations
  Putting diabetes to the test: Analyzing glycemic control based on patients' diabetes knowledge.
  Kathleen Colleran, Brian Starr, Mark R. Burge> ;Diabetes Care. 2003 Jul 1
• 55 citations
  Thiazolidinediones: A Comparative Review of Approved Uses
  Vidushi Sood, Kathleen Colleran, Mark R. Burge> ;Diabetes Technology & Therapeutics. 2000 Jan 1
• 17 citations
  Isolated Thyrotropin Deficiency Secondary to Primary Empty Sella in a Patient with Differentiated Thyroid Carcinoma: An Indication for Recombinant Thyrotropin
  Kathleen Colleran, Mark R. Burge> ;Thyroid. 1999 Dec 1
• 28 citations
  Small Cell Carcinoma of the Vagina Causing Cushing's Syndrome by Ectopic Production and Secretion of ACTH: A Case Report☆
  Kathleen Colleran, Mark R. Burge, Lida Crooks, Richard I. Dorin> ;Gynecologic Oncology. 1997 Jun 1
• 41 citations
  Building capacity to reduce disparities in diabetes: training community health workers using an integrated distance learning model.
  Kathleen Colleran, Erika Harding, Billie Jo Kipp, Andrea Zurawski, Barbara MacMillan, Lucie Jelínková, Summers Kalishman, Denise Dion, Sanjeev Arora, Dara Som> ;The Diabetes Educator. 2012 Apr 6
• Mifepristone, a glucocorticoid receptor antagonist, produces clinical and metabolic benefits in patients with Cushing's syndrome.
  Fleseriu M, Biller BM, Findling JW, Molitch ME, Schteingart DE, Gross C, SEISMIC Study Investigators> ;The Journal of clinical endocrinology and metabolism. 2012-03-30
• 205 citations
  Partnering Urban Academic Medical Centers And Rural Primary Care Clinicians To Provide Complex Chronic Disease Care
  Sanjeev Arora, Summers Kalishman, Denise Dion, Dara Som, Karla Thornton, Arthur D. Bankhurst, Jeanne Boyle, Michelle Harkins, Kathleen Moseley, Glen H. Murata, Miriam ...> ;Health Affairs. 2011 Jun 1
• 10-year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study.
  Diabetes Prevention Program Research Group, Knowler WC, Fowler SE, Hamman RF, Christophi CA, Hoffman HJ, Brenneman AT, Brown-Friday JO, Goldberg R, Venditti E, Nathan DM> ;Lancet (London, England). 2009-10-29
• 1 citations
  Hypothalamic obesity complicated by adipsic central diabetes insipidus following surgical resection of a craniopharyngioma.
  Kathleen Colleran, Leslie Sanchez-Goettler, Anita Lee Sloan> ;Journal of Clinical Hypertension. 2009 Oct 1
• Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein.
  Ridker PM, Danielson E, Fonseca FA, Genest J, Gotto AM, Kastelein JJ, Koenig W, Libby P, Lorenzatti AJ, MacFadyen JG, Nordestgaard BG, Shepherd J, Willerson JT, Glynn ...> ;The New England journal of medicine. 2008-11-09
• 22 citations
  Disparities in cardiovascular disease risk and treatment: demographic comparison.
  Kathleen Colleran, Allyson Richards, Keri Shafer> ;Journal of Investigative Medicine. 2007 Dec 1
• 3 citations
  Rimonabant: a novel approach for the treatment of obesity and cardiometabolic risk by blockade of the endocannabinoid system
  Kathleen Colleran, Hemanth K. Pai> ;Future Cardiology. 2007 Sep 3
• Join now to see all

Journal Articles

• Improvement in Insulin Sensitivity During Mifepristone Treatment of Cushing Syndrome: Early and Late Effects  
  Wallia A, Colleran KM, Purnell J, Gross C, Molitch M, Diabetes Care, 1/1/2013
• Carvedilol vs Metoprolol: A comparison of effects on endothelial function and oxidative stress in response to acute hyperglycemia in patients with type 2 diabetes and ...  
  Colleran K, Aguirre L, Burge MR, Journal of Diabetes Mellitus, 1/1/2012
• Building Capacity to Reduce Disparities in Diabetes: Training Community Health Workers Using an Integrated Distance Learning Model  
  Colleran K, Harding E Kipp B, Zurawski A, MacMillan B, Jelinkova L, Kalishman S, Dion D, Som D, and Arora S, The Diabetes Educator, 1/1/2012
• Quality Profile: Partnering Urban Academic Medical Centers and Rural Primary Care Clinicians to Provide Complex Chronic Disease Care  
  Arora S, Kalishman S, Dion D, Som D, Thornton K, Bankhurst A, Boyle J, Harkins M, Moseley K, Murata G, Komaramy M, Katzman J, Colleran K, Deming P, Yutzy S, Health Affairs, 1/1/2011
• Expanding access to hepatitis C virus treatment-Extension for Community Healthcare Outcomes (ECHO) project: disruptive innovation in specialty care  
  Arora S, Kalishman S, Thornton K, Dion D, Murata G, Deming P, Parish B, Brown J, Komaromy M, Colleran K, Bankhurst A, Katzman J, Harkins M, Curet L, Cosgrove E, Pak W, Hepatology, 1/1/2010
• Disparities in cardiovascular disease risk and treatment: demographic comparison  
  Colleran KM, Richards A, Shafer K, J Investig Med, 1/1/2008
• The Development of Diabetes Self-Management Patient Education: Achieving Glycemic Control - from referral to collaboration  
  Colleran KM, Stanfield S, Nipper M, Review of Endocrinology, 1/1/2007
• The incidence of serologic evidence of antecedent autoimmune thyroiditis in asymptomatic patients referred to an outpatient rheumatology consultation clinic for positi...  
  Twining JM, Sibbitt W, Torres-Draeger H, Colleran, K, Bankhurst AD, Clinical and Experimental Rheumatology, 1/1/2007
• Body size and shape changes and the risk of diabetes in the Diabetes Prevention Program (DPP)  
  The Diabetes Prevention Program Research Group, including Colleran K, Diabetes, 1/1/2007
• Factors associatd with diabetes onset during metformin versus placebo therapy in the Diabetes Prevention Program  
  The Diabetes Prevention Program Research Group, including Colleran K, Diabetes, 1/1/2007
• Type 2 diabetes-associated missense polymorphisms KCNJ11 E23K and ABCC8 A1369S influence progression to diabetes and response to interventions in the Diabetes Preventi...  
  The Diabetes Prevention Program Research Group, including Colleran K, Diabetes, 1/1/2007
• The prevalence of retinopathy in impaired glucose tolerance and recent-onset diabetes in the Diabetes Prevention Program  
  The Diabetes Prevention Program Research Group, including Colleran K, Diabetic Medicine, 1/1/2007
• Effects of the type 2 diabetes-associated PPARG P12A polymorphism on progression to diabetes and response to troglitazone  
  The Diabetes Prevention Program Research Group, including Colleran K, J Clin Endocrinol Metab, 1/1/2007
• Adherence to preventive medications: Predictors and outcomes in the Diabetes Prevention Program  
  The Diabetes Prevention Program Research Group, including Colleran K, Diabetes Care, 1/1/2006
• An update on the diabetes prevention program  
  The Diabetes Prevention Program Research Group, including Colleran K, Diabetes Care, 1/1/2006
• Effect of weight loss with lifestyle intervention on risk of diabetes  
  The Diabetes Prevention Program Research Group, including Colleran K, Diabetes Care, 1/1/2006
• Lifestyle intervention is associated with lower prevalence of urinary incontinence: The Diabetes Prevention Program  
  The Diabetes Prevention Program Research Group, including Colleran K, Diabetes Care, 1/1/2006
• The association among autonomic nervous system function incident diabetes and intervention arm in the Diabetes Prevention Program  
  The Diabetes Prevention Program Research Group, including Colleran K, Diabetes Care, 1/1/2006
• The association among autonomic nervous system function, incident diabetes, and intervention arm in the Diabetes Prevention Program  
  The Diabetes Prevention Program Research Group, including Colleran K, Diabetes Care, 1/1/2006
• Psychological predictors of physical activity in the Diabetes Prevention Program  
  The Diabetes Prevention Program Research Group, including Colleran K, J Am Diet Assoc, 1/1/2006
• The influence of age on the effects of lifestyle modification and metformin in prevention of diabetes  
  The Diabetes Prevention Program Research Group, including Colleran K, Journal of Gerontology, 1/1/2006
• Physical activity in individuals at risk for diabetes: Diabetes Prevention Program  
  The Diabetes Prevention Program Research Group, including Colleran K, Med Sci Sports Exerc, 1/1/2006
• Physical activity in individuals at risk for diabetes: Diabetes Prevention Program  
  The Diabetes Prevention Program Research Group, including Colleran K, Medicine & Science in Sports and Exercise, 1/1/2006
• TCF7L2 Polymorphisms and progression to diabetes in the Diabetes Prevention Program  
  The Diabetes Prevention Program Research Group, including Colleran K, NEJM, 1/1/2006
• Relationship of body size and shape to the development of diabetes in the Diabetes Prevention Program  
  The Diabetes Prevention Program Research Group, including Colleran K, Obesity, 1/1/2006
• Join now to see all

Books/Book Chapters

• Emergencies in Diabetes. 
  Chapter: Hypoglycaemia Caused by Insulin Secretagogues 
  Page 95 - 111Colleran, K, Krentz A, and Burge, MEditors: AJ Krentz.John Wiley & Sons Ltd2004
• The NORD Guide to Rare Disorders. 
  Chapter: Primary Empty Sella Syndrome 
  Colleran KLippincott, Williams & Wilkins, Philadelphia, PA2003

Abstracts/Posters

• Digital retinal imaging: community Health Workers as Imagers in Rural Areas versus an Ophthamology clinic.
  Colleran K, et al, European Association for the Study of Diabetes, Barcelona, Spain, 1/1/2013
• Assessing physician's attitudes toward community health care workers as members of the diabetes care team.
  Jones, B, Iwamoto T, and Colleran, K, Western Medical Student, Resident and Fellow Research Conference, Carmel, CA, 1/25/2012
• Effectiveness of standardization of community healthcare workers with training programs.
  Iwamoto, T and Colleran, K, Western Medical Student, Resident and Fellow Research Conference, Carmel, CA, 1/25/2012
• An innovative community health worker training program: addressing the diabetes pandemic through expansion of the diabetes health care team.
  Colleran K, Harding E, Zurawski A, Som D, Kipp B, European Association for the Study of Diabetes, Berlin, Russia, 1/1/2012
• Project ECHOs innovative CHWs training Initiatives: Outcomes Integration and Impact.
  Colleran K et al, APHA 100th Annual meeting, San Francisco, CA, 1/1/2012
• Retinal Screening Using CHWs in Rural and Underserved Communities of New Mexico: An Innovative Public/Private Collaboration
  Colleran K et al, APHA 100th Annual meeting, San Francisco, CA, 1/1/2012
• Building capacity to reduce diabetes disparities: training community health workers.
  Bouchonville, M, Colleran, K, and Kipp, B, Western Medical Student, Resident and Fellow Research Conference, Carmel, CA, 1/26/2011
• Effects of intermittent hypoxia on blood pressure and glucose metabolism in male Sprague Dawley rats
  L. Aguirre MD, Xavier De Leon MD, Karen Swezea MD, Benjamin Walker MD, Kathleen Colleran MD, and Nancy Kanagy PhD., NIH NIDDK network of Minority Research Investigators (NMRI)-national meeting, Bethesda, MD, 1/22/2010
• Effects of intermittent hypoxia on blood pressure, serum plasminogen activator 1 and glucose metabolism in male Sprague Dawley rats.
  LE Aguirre MD, X DeLeon BS, KL Sweazea PhD, BR Walker PhD, KM Colleran MD and NL Kanagy PhD, Endocrine Reviews; Endocrine Society, 1/1/2010
• A telemedicine Model Improves Attitudes to Diabetes in Medical Students Participating in a Rural Medicine Rotation in New Mexico.
  Sawyer, A, Colleran, K, Journal of Investigative Medicine, 1/1/2008
• Aggressive Pheochromocytoma: A Rare Presentation a Rare Disease Secondary to a Rare Genetic Disorder. Is there a Place for Innovative Medical Therapies?
  Podolsky, D and Colleran, K, Journal of Investigative Medicine, 1/1/2008
• Hemochromotosis Induced diabetes. Is phlebotomy curative or falsely reassuring?
  Bouchonville, M Colleran, K, Regional American College of Physicians, 1/1/2007
• A pilot study investigating the association between mindful eating and living (MEAL), weight loss, and biologic markers of inflammation and metabolism in obese subjects.
  Sloan Al, Colleran KM, Shelley B, Journal of Investigative Medicine, 1/1/2007
• Ethnic based Differences in PAI-1 Activity and Regulation
  Barchie, Panja, Colleran, Endocrine Society, 1/1/2007
• Absent Uterus and Ovaries Misdiagnosed as Delayed Puberty in a Patient with Fanconi's Anemia.
  Sloan A, Colleran K, Journal of Investigative Medicine, Carmel, CA, 1/1/2006
• Increasing Quartiles of Obesity Preferentially Alter Proatherogenic Adipocytokines
  Colleran K, Panja S, and Barchie, M, J Invest Med, 1/1/2006
• Increasing Quartiles of Obesity Preferentially Alter Proatherogenic Adipocytokines.
  Colleran K, Panja S, and Barchie, M, Annual Meeting at the Endocrine Society, Boston, MA, 1/1/2006
• Increasing Quartiles of Obesity Preferentially Alter Proatherogenic Adipocytokines.
  Colleran K, Panja S, Barchie M, Endocrine Society, Boston, MA, 1/1/2006
• Reification of Abstract Concepts to Improve Comprehension Using Interactive Virtual Environments and a Knowledge-Based Design.
  Alverson DC, Saiki Jr. SM, Caudell TP, Stevens S, Saland L, Colleran K, Brandt J, Danielson L, Cerilli L, Harris A, Gregory MC, Stewart R, Norenberg J, Shuster G, Pana..., International Association of Medical Science Educators 9th Annual Meeting, Los Angeles, CA, 1/1/2005
• A Unique Case of Cabergoline Resistant Prolactinoma.
  Nagaraja N and Colleran K, J Invest Med, 1/1/2005
• Comparative self-Reported Quality of Life among Obese Hispanics and non-Hispanic Whites
  Barchie M, Panja S, and Colleran K, J Invest Med, 1/1/2005
• Disparities In Cardiovascular Disease Risks and Treatment: A Comparison Of Hispanic And Non-Hispanic Whites
  Shafer K, Richardson A, Skipper B, Colleran K, J Invest Med, 1/1/2005
• Low Density Lipoprotein Lowering Efficacy of the Ezetimibe/Simvastatin Combination Tablet in a Large Cohort of Women
  Gallup E, Colleran K et al, Second International Conference on Women Heart Disease and Stroke, Orlando, FL, 1/1/2005
• The effect of meal composition on adipocyte derived markers of cardiovascular disease in type 2 diabetes: Role of ethnicity?
  Panja S, Barchie M, Colleran K, Diabetes, 1/1/2005
• The effect of meal composition on cardiovascular markers in patients with diabetes mellitus.
  Panja S Barchie M and Colleran, K, J Invest Med, 1/1/2005
• Join now to see all

Lectures

• Common Thyroid Dilemnas 
  1/1/2015
• An update on Type 1 Diabetes. 
  1/1/2014
• Pediatric Obesity Update 
  1/1/2013
• Pediatric Obesity 
  UNMHSC - 1/1/2012
• Expanding the Diabetes Health Care Team for Chronic Disease the Role of Community Health Workers 
  Taos, NM, 2011; UNMHSC, 2011 - 1/1/2011
• Diabetes Best Practices 
  Albuquerque, NM - 1/1/2009
• Impending Health Care Crisis as it Relates to Diabetes: Problems and Solutions 
  Albuquerque, NM - 1/1/2009
• Cardiovascular Disease and Diabetes: How they affect each other. 
  Las Clinicas Del Norte, El Rito, NM - 1/1/2009
• Diabetes Update 
  Multiple Locations, 2007, 2008, 2009 - 1/1/2009
• Approaches to Treating Obesity in the Current Epidemic. 
  Albuquerque, NM - 1/1/2008
• Community Health Workers. 
  Albuquerque, NM - 1/1/2008
• Closing the Knowledge Gap for Community Health Workers. 
  Albuquerque, NM - 1/1/2008
• A look at the Data. 
  Albuquerque, NM - 1/1/2008
• Obesity Then and Now. When will it End. 
  Multiple Locations, 2007, 2008 - 1/1/2008
• Lipid Update. 
  1/1/2008
• Update of Lipid Disorders and Treatment 
  Santa Fe, NM, 1999, 2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007 - 1/1/2007
• Diabetes What's New and What's changing 
  1/1/2005
• Cardiovascular Risk Factors in Patients with Type 2 diabetes. New Directions 
  1/1/2004
• Dysmetabolic Syndrome: Why Should We Care? 
  1/1/2003
• Race Risk and Cardiovascular Disease 
  1/1/2003
• Therapeutic Options in Type 2 DM 
  1/1/2002
• Diabetes, Hope and Micro-Hope trials. 
  University of New Mexico - 1/1/2001
• Update on Diabetes Mellitus 
  Lovelace, NM - 1/1/2000
• Women and Cardiovascular Disease 
  Santa Fe, NM - 1/1/2000
• Hyperthyroidism 
  Santa Fe, NM - 1/1/2000
• Join now to see all